Latest Insider Transactions at Accenture PLC (ACN)
This section provides a real-time view of insider transactions for Accenture PLC (ACN). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Accenture plc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Accenture plc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2019
|
Venkata S M Renduchintala Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,104
+34.07%
|
-
|
|
Feb 01
2019
|
David Rowland Executive Chairman |
SELL
Payment of exercise price or tax liability
|
Direct |
2,975
-10.87%
|
$458,150
$154.44 P/Share
|
|
Feb 01
2019
|
Arun Sarin Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,359
+18.59%
|
-
|
|
Feb 01
2019
|
Ellyn Shook Chief Leadership & HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
953
-2.62%
|
$146,762
$154.44 P/Share
|
|
Feb 01
2019
|
Ellyn Shook Chief Leadership & HR Officer |
SELL
Open market or private sale
|
Direct |
1,172
-3.12%
|
$181,660
$155.0 P/Share
|
|
Feb 01
2019
|
Julie Spellman Sweet Chair and CEO |
SELL
Open market or private sale
|
Direct |
3,301
-5.19%
|
$508,354
$154.55 P/Share
|
|
Feb 01
2019
|
Frank Kui Tang Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,072
+17.59%
|
-
|
|
Feb 01
2019
|
Tracey Thomas Travis Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,764
+28.76%
|
-
|
|
Feb 01
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
SELL
Payment of exercise price or tax liability
|
Direct |
1,668
-1.28%
|
$256,872
$154.44 P/Share
|
|
Feb 01
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
SELL
Open market or private sale
|
Direct |
2,000
-1.52%
|
$310,000
$155.0 P/Share
|
|
Jan 25
2019
|
David Rowland Executive Chairman |
SELL
Open market or private sale
|
Direct |
2,883
-9.53%
|
$435,333
$151.75 P/Share
|
|
Jan 18
2019
|
David Rowland Executive Chairman |
SELL
Open market or private sale
|
Direct |
2,916
-8.79%
|
$437,400
$150.0 P/Share
|
|
Jan 18
2019
|
Ellyn Shook Chief Leadership & HR Officer |
SELL
Open market or private sale
|
Direct |
1,172
-3.03%
|
$175,800
$150.0 P/Share
|
|
Jan 18
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
SELL
Open market or private sale
|
Direct |
2,000
-1.49%
|
$300,000
$150.0 P/Share
|
|
Jan 17
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
SELL
Open market or private sale
|
Indirect |
1,000
-50.0%
|
$148,000
$148.48 P/Share
|
|
Jan 17
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
SELL
Open market or private sale
|
Direct |
1,000
-0.74%
|
$148,000
$148.48 P/Share
|
|
Jan 07
2019
|
Daniel T London Group Chief Exec - Health & PS |
SELL
Open market or private sale
|
Direct |
3,610
-5.54%
|
$509,010
$141.36 P/Share
|
|
Jan 05
2019
|
Omar Abbosh Grp Chief Exec-Com, Med & Tech |
SELL
Payment of exercise price or tax liability
|
Direct |
195
-0.47%
|
$27,105
$139.42 P/Share
|
|
Jan 05
2019
|
Omar Abbosh Grp Chief Exec-Com, Med & Tech |
BUY
Grant, award, or other acquisition
|
Direct |
987
+1.17%
|
$68,103
$69.71 P/Share
|
|
Jan 05
2019
|
Richard P Clark Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
448
-4.05%
|
$62,272
$139.42 P/Share
|
|
Jan 05
2019
|
Richard P Clark Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,377
+5.74%
|
$95,013
$69.71 P/Share
|
|
Jan 05
2019
|
Chad T Jerdee General Counsel and CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
347
-2.19%
|
$48,233
$139.42 P/Share
|
|
Jan 05
2019
|
Chad T Jerdee General Counsel and CCO |
BUY
Grant, award, or other acquisition
|
Direct |
1,203
+3.59%
|
$83,007
$69.71 P/Share
|
|
Jan 05
2019
|
Daniel T London Group Chief Exec - Health & PS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,059
-3.07%
|
$147,201
$139.42 P/Share
|
|
Jan 05
2019
|
Daniel T London Group Chief Exec - Health & PS |
BUY
Grant, award, or other acquisition
|
Direct |
2,290
+3.16%
|
$158,010
$69.71 P/Share
|
|
Jan 05
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
SELL
Payment of exercise price or tax liability
|
Direct |
1,197
-0.88%
|
$166,383
$139.42 P/Share
|
|
Jan 05
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
BUY
Grant, award, or other acquisition
|
Direct |
4,963
+1.8%
|
$342,447
$69.71 P/Share
|
|
Jan 05
2019
|
Ellyn Shook Chief Leadership & HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
935
-2.36%
|
$129,965
$139.42 P/Share
|
|
Jan 05
2019
|
Ellyn Shook Chief Leadership & HR Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,127
+2.58%
|
$146,763
$69.71 P/Share
|
|
Jan 05
2019
|
Julie Spellman Sweet Chair and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
389
-1.73%
|
$54,071
$139.42 P/Share
|
|
Jan 05
2019
|
Julie Spellman Sweet Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
1,320
+2.8%
|
$91,080
$69.71 P/Share
|
|
Jan 05
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
SELL
Payment of exercise price or tax liability
|
Direct |
1,356
-1.0%
|
$188,484
$139.42 P/Share
|
|
Jan 05
2019
|
Noordende Alexander M Van 'T Group Chief Exec-Products |
BUY
Grant, award, or other acquisition
|
Direct |
2,640
+0.96%
|
$182,160
$69.71 P/Share
|
|
Jan 01
2019
|
Omar Abbosh Grp Chief Exec-Com, Med & Tech |
SELL
Payment of exercise price or tax liability
|
Direct |
2,780
-6.36%
|
$389,200
$140.34 P/Share
|
|
Jan 01
2019
|
Omar Abbosh Grp Chief Exec-Com, Med & Tech |
BUY
Grant, award, or other acquisition
|
Direct |
5,344
+10.89%
|
-
|
|
Jan 01
2019
|
Gianfranco Casati CEO-Growth Markets |
BUY
Grant, award, or other acquisition
|
Direct |
5,344
+9.4%
|
-
|
|
Jan 01
2019
|
Richard P Clark Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
165
-1.68%
|
$23,100
$140.34 P/Share
|
|
Jan 01
2019
|
Richard P Clark Chief Accounting Officer |
BUY
Grant, award, or other acquisition
|
Direct |
2,685
+21.43%
|
-
|
|
Jan 01
2019
|
Johan Deblaere Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
212
-0.27%
|
$29,680
$140.34 P/Share
|
|
Jan 01
2019
|
Johan Deblaere Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,344
+6.45%
|
-
|
|
Jan 01
2019
|
Chad T Jerdee General Counsel and CCO |
SELL
Payment of exercise price or tax liability
|
Direct |
843
-5.43%
|
$118,020
$140.34 P/Share
|
|
Jan 01
2019
|
Chad T Jerdee General Counsel and CCO |
BUY
Grant, award, or other acquisition
|
Direct |
3,740
+19.42%
|
-
|
|
Jan 01
2019
|
Daniel T London Group Chief Exec - Health & PS |
SELL
Payment of exercise price or tax liability
|
Direct |
1,712
-5.04%
|
$239,680
$140.34 P/Share
|
|
Jan 01
2019
|
Daniel T London Group Chief Exec - Health & PS |
BUY
Grant, award, or other acquisition
|
Direct |
5,344
+13.61%
|
-
|
|
Jan 01
2019
|
Richard Lumb Group Chief Executive-Fin Serv |
BUY
Grant, award, or other acquisition
|
Direct |
5,344
+3.91%
|
-
|
|
Jan 01
2019
|
Pierre Nanterme Chairman & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
23,158
+5.88%
|
-
|
|
Jan 01
2019
|
Jean Marc Ollagnier CEO EMEA |
SELL
Payment of exercise price or tax liability
|
Direct |
43
-0.03%
|
$6,020
$140.34 P/Share
|
|
Jan 01
2019
|
Jean Marc Ollagnier CEO EMEA |
BUY
Grant, award, or other acquisition
|
Direct |
5,344
+3.03%
|
-
|
|
Jan 01
2019
|
David Rowland Executive Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
8,728
+20.83%
|
-
|
|
Jan 01
2019
|
Ellyn Shook Chief Leadership & HR Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
494
-1.3%
|
$69,160
$140.34 P/Share
|